The Bone and Soft Tissue Tumors Program at Children's Hospital Los Angeles provides one of the most well-rounded cancer treatment programs for kids, caring for more children with bone and soft tissue tumors than any other pediatric hospital west of the Mississippi River.
Orthopaedic surgeons from Children’s Orthopaedic Center team with oncologists and other specialists in Children's Center for Cancer and Blood Diseases to treat bone and soft tissue cancers, such as sarcomas, focusing on early diagnosis, quality of life and long-term follow-up.
They treat both benign and malignant tumors, with the goal of using minimally invasive techniques, when possible, that prompt return to physical activities. Comprehensive treatment for patients with cancerous tumors includes chemotherapy and surgery, as well as support from social workers, therapists and child life specialists.
Our specialists use leading-edge technology for tumor reconstruction and perform the largest number of procedures, including:
The Bone and Soft Tissue Tumor Program is nationally recognized for advancing treatments for children with tumors such as:
Benign bone tumors are non-cancerous tumors that are often diagnosed following a minor trauma, fracture or history of pain. Upon discovery of a bone abnormality, the Bone and Soft Tissue Tumors team will perform an evaluation, determine if the tumor is malignant or benign and decide the type of medical or surgical treatment best suited for that particular lesion.
Malignant bone and soft tissue sarcomas, cancerous tumors, relatively rare, but disproportionately affect children, adolescents and young adults. Tremendous strides have been made in improving the survival of children and adolescents with sarcoma. Continued efforts are aimed to also improve their quality of life during their very productive years.
Orthopaedic surgeons with the Bone and Soft Tissue Tumors program care for children with bone cancer before and after the diagnosis is made. Because the location of the tumor biopsy, it often affects the ability to optimally treat a cancerous limb, referring physicians are urged to consult with orthopaedic surgeons at Children's Hospital Los Angeles before conducting an independent work-up and biopsy.
Bone and soft tissue tumor treatment includes chemotherapy and surgery, as well as extensive family and child support from the care team. The primary surgical goals in treating malignant tumors are to remove the tumor and, if possible, save the normal parts of the limb. Over 90% of the patients are able to receive limb-sparing procedures. Orthopaedic surgeons use the latest limb-sparing techniques, excising the tumor and replacing the affected bone with other bone or an artificial joint replacement. Following surgery, patients undergo an extensive inpatient rehabilitation program to regain use of the affected limb.
In soft tissue tumors, the Bone and Soft Tissue Tumors program has spearheaded limb-sparing procedures, combining high-dose chemotherapy to reduce tumor size and advanced surgical techniques.
In the past, bone cancers of the extremities were treated by amputation. Over the last three decades, the Children’s Orthopaedic Center and Center for Cancer and Blood Diseases have collaborated to develop and refine techniques for limb salvage and reconstruction. Together, with advanced chemotherapy, these can save the affected limb in a vast majority of cases. Following removal of the tumor, “growing prosthesis” may be implanted to allow normal skeletal growth. As a child grows and ages, the doctors then lengthen the prosthesis over time.
The Bone and Soft Tissue Tumors program provides a comprehensive team of uniquely trained physicians, equipped with several years of experience, in the treatment of complex and rare tumors.
Parents and children receive the time and attention they deserve through personalized care. It is important to make sure they understand the condition, treatment and prognosis, and our staff encourages families to participate in additional support groups. The team is also composed of social workers, child life specialists, and an oncology trained nursing.
Bone and Soft Tissue Tumor Research
One of the unique characteristics of the Bone and Soft Tissue Program is the multidisciplinary integration, at not only a clinical but also a research level, including clinical and translational research as well as basic science. We have several current research initiatives aimed at the better understanding and management of childhood benign and malignant tumors.
Oncologists at Children's Hospital Los Angeles are also developing novel drug therapies to both increase the survival rates for patients with bone and soft tissue tumors, as well as minimize side effects.
Specific areas of interest, include: